Next Article in Journal
Vitamin D as a Systemic Regulatory Axis: From Homeostasis to Multiorgan Disease
Previous Article in Journal
Remote Hemodynamic Monitoring in Heart Failure Management: A Comprehensive Review of Recent Advances and Clinical Challenges
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Article

Immunohistochemical Expression of TNFR1, IL-6, and TGF-β1 in the Synovial Tissue of Patients with Hip Osteoarthritis

1
Department of Anatomy, Histology and Embryology, School of Medicine, University of Split, 21000 Split, Croatia
2
Department of Emergency Medicine, University Hospital of Split, Spinciceva 1, 21000 Split, Croatia
3
Surgery Department, Orthopaedics and Traumatology Division, University Hospital of Split, Spinciceva 1, 21000 Split, Croatia
4
Department of Family Medicine, Health Center Mostar, Bulevar Hrvatskih Branitelja b.b., 88000 Mostar, Bosnia and Herzegovina
5
Center for Translational Research in Biomedicine, University of Split School of Medicine, Soltanska 2, 21000 Split, Croatia
6
Mediterranean Institute for Life Sciences, University of Split, Meštrovićevo Šetalište 45, 21000 Split, Croatia
*
Author to whom correspondence should be addressed.
Biomedicines 2025, 13(11), 2732; https://doi.org/10.3390/biomedicines13112732 (registering DOI)
Submission received: 19 September 2025 / Revised: 21 October 2025 / Accepted: 6 November 2025 / Published: 7 November 2025
(This article belongs to the Section Cell Biology and Pathology)

Abstract

Background/Objectives: Hip osteoarthritis (HOA) is a progressive joint disease characterized by cartilage loss, subchondral bone changes, and synovial inflammation. While tumor necrosis factor receptor 1 (TNFR1), interleukin-6 (IL-6), and transforming growth factor-beta 1 (TGF-β1) are recognized as key mediators of joint pathology, their compartment-specific expression in the human hip synovium remains insufficiently characterized. Therefore, we aimed to investigate their localization and expression in the intimal and subintimal compartments of synovial tissue in patients with HOA compared to controls (CTRL). Methods: Synovial membrane samples were obtained from 19 patients with primary HOA undergoing total hip arthroplasty and 10 CTRL subjects undergoing arthroplasty for acute femoral neck fracture without HOA. Specimens were processed for hematoxylin and eosin (H&E) and immunofluorescence staining. Expression of TNFR1, IL-6, and TGF-β1 was quantified in the intima and subintima using ImageJ analysis. Group differences were assessed using two-way Analysis of variance (ANOVA) with Tukey’s test when assumptions were met; for heteroscedastic outcomes we applied Brown–Forsythe ANOVA with Dunnett’s T3 multiple comparisons. Results: Histological analysis confirmed synovitis in HOA samples, with intimal hyperplasia and mononuclear infiltration. IL-6 was significantly upregulated in the intima of HOA synovium compared with CTRLs, while subintimal expression remained unchanged. In contrast, TGF-β1 expression was reduced in the HOA intima, eliminating the normal intima–subintima gradient. For TNFR1, the within-HOA contrast (int > sub) was significant, whereas the intimal HOA vs. CTRL comparison showed a non-significant trend. Transcriptomic analysis supported IL-6 upregulation, while TNFR1 and TGF-β1 did not reach statistical significance at the mRNA level in an orthogonal, non-hip (knee-predominant) dataset. Conclusions: These findings demonstrate compartment-specific cytokine dysregulation in HOA, with increased intimal TNFR1 and IL-6 alongside reduced intimal TGF-β1. The synovial lining emerges as a dominant site of inflammatory signaling, underscoring its importance in disease progression.
Keywords: hip osteoarthritis (HOA); synovial membrane; tumor necrosis factor receptor 1 (TNFR1); interleukin-6 (IL-6); transforming growth factor beta 1 (TGF-β1); Immunofluorescence hip osteoarthritis (HOA); synovial membrane; tumor necrosis factor receptor 1 (TNFR1); interleukin-6 (IL-6); transforming growth factor beta 1 (TGF-β1); Immunofluorescence

Share and Cite

MDPI and ACS Style

Todorović, P.; Jurić, I.; Kelam, N.; Rošin, M.; Čarić, D.; Boban, D.; Kopilaš, A.; Vukojević, K. Immunohistochemical Expression of TNFR1, IL-6, and TGF-β1 in the Synovial Tissue of Patients with Hip Osteoarthritis. Biomedicines 2025, 13, 2732. https://doi.org/10.3390/biomedicines13112732

AMA Style

Todorović P, Jurić I, Kelam N, Rošin M, Čarić D, Boban D, Kopilaš A, Vukojević K. Immunohistochemical Expression of TNFR1, IL-6, and TGF-β1 in the Synovial Tissue of Patients with Hip Osteoarthritis. Biomedicines. 2025; 13(11):2732. https://doi.org/10.3390/biomedicines13112732

Chicago/Turabian Style

Todorović, Petar, Ivana Jurić, Nela Kelam, Matko Rošin, Davor Čarić, Danica Boban, Andrea Kopilaš, and Katarina Vukojević. 2025. "Immunohistochemical Expression of TNFR1, IL-6, and TGF-β1 in the Synovial Tissue of Patients with Hip Osteoarthritis" Biomedicines 13, no. 11: 2732. https://doi.org/10.3390/biomedicines13112732

APA Style

Todorović, P., Jurić, I., Kelam, N., Rošin, M., Čarić, D., Boban, D., Kopilaš, A., & Vukojević, K. (2025). Immunohistochemical Expression of TNFR1, IL-6, and TGF-β1 in the Synovial Tissue of Patients with Hip Osteoarthritis. Biomedicines, 13(11), 2732. https://doi.org/10.3390/biomedicines13112732

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop